Skip to content

Efficacy of Pattern Respiratory PNF Associated Aerobic Training on Lung Volumes and 6MWT Test in Parkinson Individuals

Efficacy of Pattern Respiratory Proprioceptive Neuromuscular Facilitation Associated With Aerobic Training on the Volumes, Lung Capacity and Six-minute Walking Test in Individuals With Parkinson: Randomized Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02600052
Enrollment
30
Registered
2015-11-09
Start date
2016-05-31
Completion date
2017-04-30
Last updated
2016-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Brief summary

INTRODUCTION: Parkinson's disease (PD) is a neurodegenerative disorder that causes motor disorders such as bradykinesia, rigidity and tremor. In addition to the motor symptoms occurring in the overall PD patients, mostly there is associated respiratory disorders. The respiratory impairment may be due by postural changes, limiting the flexibility and expandability of the chest wall causing decreased lung volumes and flows. So the exercise Proprioceptive Neuromuscular Facilitation (PNF) is a tool designed to reduce the changes in respiratory function, the commitment of the respiratory muscles, and allows greater flexibility of the chest wall, reducing the rigidity of the rib cage. To evaluate the effects of respiratory pattern of Proprioceptive Neuromuscular Facilitation on the distribution of pulmonary ventilation, compartmental volumes of diaphragmatic mobility and functional capacity in patients with Parkinson's disease. METHODS: The study is a clinical trial randomized, in which participants to be elected for the study should present diagnosis of PD, staging of disease between II and III according to Hoehn and Yahr. Initially, the participants will undergo the collection of data on medical history, assessment of pulmonary function by spirometry and respiratory muscle strength measured by the manometer. Then will undergo evaluation of the breathing pattern and tricompartmental distribution of the volume of the chest wall by hemithorax by Plethysmography Optoelectronic; Quantify the mobility of the right diaphragm in total lung capacity for maneuver and during the current volume by ultrasonography. After the evaluation, participants will undergo intervention which will consist of three stages: first occur first session of the PNF later aerobic training for 30 minutes, ending with one PNF session.

Interventions

OTHERPNF

RESPIRATORY PATTERN PROPRIOCEPTIVE NEUROMUSCULAR FACILITATION

DEVICEtreadmill

AEROBIC TRAINING

Sponsors

Universidade Federal de Pernambuco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Individuals with stage II and III between the Hoehn and Yahr classification; * minimum score of 28 on the Mini Mental Examination for Parkinson.

Exclusion criteria

* individuals with rheumatologic or orthopedic diseases or deformities / abnormalities in the spine that compromise the respiratory mechanics; * respiratory comorbidities; * history of smoking; * history of thoracic or abdominal surgery; * clinical instability characterized by infections and / or hemodynamic defined as greater than 150 bpm heart rate or systolic blood pressure less than 90 mmHg; * Not present exchange of the drug in the last 30 days.

Design outcomes

Primary

MeasureTime frameDescription
LUNG VOLUME1 MONTHBY OPTOELECTRONIC PLETHYSMOGRAPHY
WALKING DISTANCE, VO2, VCO21 MONTHSIX-MINUTE WALK TEST PLUS CÓRTEX

Secondary

MeasureTime frameDescription
DIAPHRAGM MOBILITY1 MONTHULTRASOUND
DIAPHRAGM THICKNESS1 MONTHULTRASOUND

Other

MeasureTime frameDescription
PRESSURE RESPIRATORY MAXIMAL1 MONTHBY MANOVACUOMETER

Countries

Brazil

Contacts

Primary ContactCarlos Rego Barros
carlosregobarros@hotmail.com+55 81 21268496
Backup ContactArmele Dornelas
armeledornelas@yahoo.com+55 81 21268496

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026